MENS Jyong Biotech Ltd.
Fundamentals / CIK 0001954488 / USDJyong Biotech Ltd. reported $20.78M in total assets and a net loss of $4.67M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MENS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$2.61M Operating profit
-
Net Income FY 2025-$4.67M GAAP bottom line
-
Diluted EPS FY 2025-$0.06 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$1.18M Total debt: $15.44M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $813K | $927K | $1.07M |
| Selling, General & Admin | $1.79M | $1.13M | $1.73M |
| Total Operating Expenses | $2.61M | $2.06M | $2.80M |
| Operating Income | -$2.61M | -$2.06M | -$2.80M |
| EBITDA | -$2.51M | -$1.94M | -$2.67M |
| Interest Income | $610K | $7.0K | $56K |
| Interest Expense | $2.54M | $1.03M | $757K |
| Income Before Tax | -$4.67M | -$3.02M | -$4.40M |
| Net Income | -$4.67M | -$3.02M | -$4.40M |
| Basic EPS | -$0.06 | -$0.04 | -$0.06 |
| Diluted EPS | -$0.06 | -$0.04 | -$0.06 |
| Basic Shares Outstanding | 73.0M | 71.6M | 71.6M |
| Diluted Shares Outstanding | 73.0M | 71.6M | 71.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $1.18M | $98K |
| Cash & Short-Term Investments | $1.18M | $98K |
| Total Current Assets | $15.54M | $206K |
| Property, Plant & Equipment, Net | $3.09M | $3.05M |
| Other Non-Current Assets | $6.0K | $6.0K |
| Total Non-Current Assets | $5.24M | $6.16M |
| Total Assets | $20.78M | $6.37M |
| Accounts Payable | $2.0K | $3.0K |
| Short-Term Debt | $15.34M | -- |
| Other Current Liabilities | $3.45M | $3.29M |
| Total Current Liabilities | $34.81M | $12.13M |
| Other Non-Current Liabilities | $60K | $58K |
| Total Non-Current Liabilities | $10.87M | $30.76M |
| Total Liabilities | $45.68M | $42.88M |
| Total Debt (incl. Leases) | $15.44M | $175K |
| Common Stock | $1.0K | $1.0K |
| Retained Earnings | -$37.75M | -$33.08M |
| Accumulated Other Comp. Income | $682K | $1.12M |
| Total Stockholders' Equity | -$24.91M | -$36.52M |
| Total Equity | -$24.91M | -$36.52M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash & Cash Equivalents | $1.18M | $98K |
| Cash & Short-Term Investments | $1.18M | $98K |
| Total Current Assets | $15.54M | $206K |
| Property, Plant & Equipment, Net | $3.09M | $3.05M |
| Other Non-Current Assets | $6.0K | $6.0K |
| Total Non-Current Assets | $5.24M | $6.16M |
| Total Assets | $20.78M | $6.37M |
| Accounts Payable | $2.0K | $3.0K |
| Short-Term Debt | $15.34M | -- |
| Other Current Liabilities | $3.45M | $3.29M |
| Total Current Liabilities | $34.81M | $12.13M |
| Other Non-Current Liabilities | $60K | $58K |
| Total Non-Current Liabilities | $10.87M | $30.76M |
| Total Liabilities | $45.68M | $42.88M |
| Total Debt (incl. Leases) | $15.44M | $175K |
| Common Stock | $1.0K | $1.0K |
| Retained Earnings | -$37.75M | -$33.08M |
| Accumulated Other Comp. Income | $682K | $1.12M |
| Total Stockholders' Equity | -$24.91M | -$36.52M |
| Total Equity | -$24.91M | -$36.52M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$4.67M | -$3.02M | -$4.40M |
| Depreciation & Amortization | $100K | $120K | $127K |
| Change in Payables | -$1.0K | $1.0K | -$2.0K |
| Operating Cash Flow | -$3.04M | -$3.62M | -$2.60M |
| Investing Cash Flow | -$13.51M | -- | $95K |
| Common Stock Issued | $17.77M | -- | -- |
| Financing Cash Flow | $17.63M | $1.99M | $2.03M |
| Net Change in Cash | $1.08M | -$1.64M | -$532K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Assets (ROA) | -22.5% | -47.4% | -- |
| Current Ratio | 0.45x | 0.02x | -- |
| Quick Ratio | 0.03x | 0.01x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.